T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
about
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
P2860
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
T cells in chronic lymphocytic ...... points and activation markers.
@ast
T cells in chronic lymphocytic ...... points and activation markers.
@en
T cells in chronic lymphocytic ...... points and activation markers.
@nl
type
label
T cells in chronic lymphocytic ...... points and activation markers.
@ast
T cells in chronic lymphocytic ...... points and activation markers.
@en
T cells in chronic lymphocytic ...... points and activation markers.
@nl
prefLabel
T cells in chronic lymphocytic ...... points and activation markers.
@ast
T cells in chronic lymphocytic ...... points and activation markers.
@en
T cells in chronic lymphocytic ...... points and activation markers.
@nl
P2093
P2860
P1433
P1476
T cells in chronic lymphocytic ...... points and activation markers.
@en
P2093
Anders Österborg
Barbro Näsman-Glaser
Emma Young
Fariba Mozaffari
Giusy Gentilcore
Håkan Mellstedt
Kia Heimersson
Marzia Palma
Richard Rosenquist
P2860
P304
P356
10.3324/HAEMATOL.2016.151100
P577
2016-12-07T00:00:00Z